跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SAMAKIND sugammadex (as sodium) 500 mg/5 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
SAMAKIND sugammadex (as sodium) 500 mg/5 mL solution for injection vial
Approved
STANDARD
SAMAKIND sugammadex (as sodium) 500 mg/5 mL solution for injection vial
Maple Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
cec5933e702fa7d3
Company
Maple Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
cec5933e702fa7d3
Product Name
SAMAKIND sugammadex (as sodium) 500 mg/5 mL solution for injection vial
Artg Id
418931
Artg Name
SAMAKIND sugammadex (as sodium) 500 mg/5 mL solution for injection vial
Sponsor
Maple Healthcare Pty Ltd
Company Detail Path
/organization/maple-healthcare-pty-ltd
Artg Date
2024-11-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
cec5933e702fa7d3
Type
Standard
Back to TGA Approvals